MedTrace Logo

Osteogenic Potential of Cissus Quadrangularis Alveolar Ridge Distraction

NCT04669795 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 20

Last updated 2020-12-17

No results posted yet for this study

Summary

Deficient alveolar mandibular ridge corrected distraction osteogenesis to facilitate dental implant placement. Patients grouped into 2 groups: one group received Cissus quadrangularis during the consolidation period, and the other group received placebo.

Conditions

  • Distraction of Bone
  • Dental Implant

Interventions

DRUG

Cissus Quadrangularis

Drug with osteogenic potential given to the patients after consolidation period. dose was two capsules once /day with meals for 6 weeks

Sponsors & Collaborators

  • Al-Azhar University

    lead OTHER

Principal Investigators

  • Altaweel · Al-Alharby university

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
30 Years
Max Age
55 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2017-04-15
Primary Completion
2019-05-30
Completion
2019-08-15

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04669795 on ClinicalTrials.gov